<bill session="112" type="h" number="6433" updated="2013-07-20T02:05:29-04:00">
  <state datetime="2012-10-05">ENACTED:SIGNED</state>
  <status>
    <unknown datetime="2012-10-05"/>
  </status>
  <introduced datetime="2012-09-19"/>
  <titles>
    <title as="passed house" type="short">FDA User Fee Corrections Act of 2012</title>
    <title as="passed senate" type="short">FDA User Fee Corrections Act of 2012</title>
    <title as="enacted" type="short">FDA User Fee Corrections Act of 2012</title>
    <title as="introduced" type="official">To make corrections with respect to Food and Drug Administration user fees.</title>
  </titles>
  <sponsor id="400414"/>
  <cosponsors>
    <cosponsor id="400425" joined="2012-09-19"/>
  </cosponsors>
  <actions>
    <action state="REFERRED" datetime="2012-09-19">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2012-09-19T20:50:00-04:00">
      <text>Mr. Upton asked unanimous consent to discharge from committee and consider.</text>
    </action>
    <action datetime="2012-09-19T20:50:00-04:00">
      <text>Committee on Energy and Commerce discharged.</text>
    </action>
    <action datetime="2012-09-19T20:50:00-04:00">
      <text>Considered by unanimous consent.</text>
      <reference ref="CR H6137-6138" label="consideration"/>
    </action>
    <vote state="PASS_OVER:HOUSE" datetime="2012-09-19T20:50:00-04:00" how="without objection" result="pass" type="vote" where="h">
      <text>On passage Passed without objection.</text>
      <reference ref="CR H6137-6138" label="text"/>
    </vote>
    <action datetime="2012-09-19T20:50:00-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2012-09-20">
      <text>Received in the Senate, read twice.</text>
    </action>
    <vote state="PASSED:BILL" datetime="2012-09-22" how="by Unanimous Consent" result="pass" type="vote2" where="s">
      <text>Passed Senate without amendment by Unanimous Consent.</text>
      <reference ref="CR 9/21/2012 S6671" label="consideration"/>
    </vote>
    <action datetime="2012-09-24">
      <text>Message on Senate action sent to the House.</text>
    </action>
    <topresident datetime="2012-09-25">
      <text>Presented to President.</text>
    </topresident>
    <signed datetime="2012-10-05">
      <text>Signed by President.</text>
    </signed>
    <enacted state="ENACTED:SIGNED" datetime="2012-10-05" type="public" number="112-193">
      <text>Became Public Law No: 112-193.</text>
    </enacted>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" activity="Referral, Discharged"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Appropriations"/>
    <term name="Department of Health and Human Services"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Executive agency funding and structure"/>
    <term name="Food and Drug Administration (FDA)"/>
    <term name="Prescription drugs"/>
    <term name="User charges and fees"/>
  </subjects>
  <amendments/>
  <summary>10/5/2012--Public Law.
FDA User Fee Corrections Act of 2012 - Amends the Federal Food, Drug, and Cosmetic Act (FFDCA), as amended by the Food and Drug Administration Safety and Innovation Act (P.L. 112-144), to: (1) make clerical corrections to provisions of such Act; and (2) eliminate the restriction that appropriated funds shall be available only for payment of increases in the cost of reviewing medical device applications, including related personnel costs. Specifies due dates in FY2013 under FFDCA for the drug master file fee, the abbreviated new drug application and prior approval supplement filing fees, and the generic drug facility and active pharmaceutical ingredient facility fees.</summary>
</bill>
